Fluoroquinolones in pediatrics and their nephrotoxicity in adults: Minireview

Journal of Chemotherapy

Volumn 12, Issue 3, 2000, Pages 228-231

  Fanos, Vassilios ^a   Cuzzolin, L ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Fluoroquinolones; Nephrotoxicity; Pediatric UTI; Pharmacokinetics; Quinolones; Urinary tract infection; UTI in children

Indexed keywords

CIPROFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE PREDISPOSITION; DRUG MONITORING; HUMAN; INFANT; NEPHROTOXICITY; RISK BENEFIT ANALYSIS; URINARY TRACT INFECTION;

EID: 0034088208     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.3.228     Document Type: Article

References (31)

1. 1 Nix DE, Schentag JJ. The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodinamics. J Clin Pharmacol 1988; 28: 169-178.
2. 2 Von Rosenstiel N, Adam D. Quinolone antibacterials -an update of their pharmacology and therapeutic use. Drugs 1993; 47: 371-401.
3. 3 Dagan R. Fluoroquinolones in paediatrics-1995. Drugs 1995; 49(S2): 92-99.
4. 4 Van der Oever HLA, Versteegh FGA, Thewessen EAPM, van den Anker JN, Mouton JW, Neijens HJ. Ciprofloxacin in preterm neonates: case report and review of the literature. Eur J Pediatr 1998; 157: 843-845.
5. 5 Shaad UB. Use of the quinolones in paediatrics. Drugs 1993; 45 (S3): 37-41.
6. 6 Mangiarotti P, Pizzini C, Fanos V. Antibiotic prophylaxis in children with relapsing urinary tract infections. J Chemother 2000; 12 (2): 115-123.
7. 7 Lietman PS. Fluorquinolone toxicities. An update. Drugs 1995; 49 (S2): 159-163.
8. 8 Christ W, Lehnert T, Uklbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988; 10: 141-146.
9. 9 Danisovicovà A, Krcméryova T, Belan S, et al. Magnetic resonance imaging in diagnosis of potential arthropathogenicity in children receiving quinolones. No evidence of quinolone-induced arthropathy. Drugs 1995; 49 (S2): 492-494.
10. 10 Hooper DC, Wolfson JS. The fluoroquinolones: pharmacology, clinical uses and toxicities in humans. Antimicrob Agents Chemother 1985; 28: 716-721.
11. 11 Lode H. Pharmacokinetics and clinical results of parenterally administered new quinolones in humans. Rev Infect Dis 1989; 11(S5): 996-1004.
12. 12 Valdvogel FA. Clinical role of the quinolones today and in the future. Eur J Clin Microbiol Infect Dis 1989; 8: 1075-1079.
13. 13 Norrby SR. Side-effects of quinolones: comparisons between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis 1991; 10(4): 378-383.
14. 14 Peltola H, Vaarala M, Renkonen O, Neuvonen PJ. Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children. Antimicrob Agents Chemother 1992; 36(5): 1086-1090.
15. 15 Bethell DB, Day NPJ, Dung NM, et al. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. Antimicrob Agents Chemother 1996; 40(9): 2167-2172.
16. 16 Rubio TT, Miles MV, Church DA, Echols RM, Pickerin LK. Pharmacokinetic studies of ciprofloxacin in children with cystic fibrosis. Pediatr Res 1994; 35: 195A.
17. 17 Smith AL, Weber A, Pandher R, Williams-Warren J, Cohen ML, Ramsey B. Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis. Infection 1997; 25(2): 106-108.
18. 18 Peltola H, Ukkonen P, Saxen H, Stass H. Single-dose and steady-state pharmacokinetics of a new oral suspension of ciprofloxacin in children. Pediatrics 1998; 101 (4Pt1): 658-662.
19. 19 Brun P. Utlization des quinolones dans le traitment des infectiones urinaires de l'enfant. In: Quinolones en pediatrie. Flammarion Mèdicine Sciences, 1992; 99-104.
20. 20 Fanos V, Khoory BJ. Antimicrobial survey of urinary tract isolates in paediatrics. J Chemother 1999; 11 (4): 255-259.
21. 21 Fujii R. The use of norfloxacin in children in Japan. Adv Antimicrob Antineopl Chemother 1992; 11-2: 219-230.
22. 22 Van Wijk JAE, de Jong TPVM, Van Gool JD. Using quinolones in urinary tract infections in children. Adv Antimicrob Antineopl Chemother 1992; 11-2: 157-161.
23. 23 Kaloyanides GJ. Antibiotic-related nephrotoxicity. Nephrol Dial Transpl 1994; 9 (S4): 130-134.
24. 24 Fanos V, Cataldi L. Antibacterial-induced nephrotoxicity in the newborn. Drug Safety 1999; 20 (3): 245-267.
25. 25 Hootkins R, Fenves AZ, Stephens MK. Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and review of the literature. Clin Nephrol 1989; 32: 75-78.
26. 26 Lien YH, Hansen R, Kern WF. Ciprofloxacin-induced granulomatous interstitial nephritis and localized elastolysis. Am J Kidney Dis 1993; 22: 598-602.
27. 27 Dharnidharka VR, Nadeau K, Cannon CL. Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis 1998; 31: 481-485.
28. 28 Allon M, Lopez EJ, Min KW. Acute renal failure due to ciprofloxacin. Arch Intern Med 1990; 150: 2187-2189.
29. 29 Blum MD, Graham DJ, McClosey CA. Temafloxacin syndrome: review of 95 cases. Clin Infect Dis 1994; 18: 946-950.
30. 30 Thorsteinsson SB, Bergan T, Oddsdottir S, et al. Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy 1986; 32: 408-417.
31. 31 Paton JH, Reeves DS. Clinical features and management of adverse effects of quinolone antibacterials. Drug Safety 1991; 6(1): 8-27.